ClinicalTrials.gg

Drug

Remimazolam besilate clinical trials

Also written Remimazolam besylate and Byfavo.

studies test it
47
open now
20
in phase 3
5
first study started
2021

Keep track of what changes. Save the remimazolam besilate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

47 studies that test it; most in 2022 (14)

Studies that test remimazolam besilate, by start year
YearStudies
20213
202214
202311
20247
20258
20264

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
2
Phase 2
5
Phase 3
5
Phase 4
13
No phase
21

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 0 · Other 47

Seoul National University Hospital (6) · Yonsei University (3) · Wuhan Union Hospital, China (3) · Seoul National University Bundang Hospital (3) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (2) · University Hospital of Split (2) · Pusan National University Yangsan Hospital (2) · Second Affiliated Hospital of Wenzhou Medical University (2)

Often tested with

Tested in the same studies.

Propofol (5) · Flumazenil (2) · Midazolam (2) · Esketamine (1) · Ketamine (1) · Sevoflurane (1)

Studies

Open first, then newest update. How each study uses remimazolam besilate is read from its arms, and is right about nine times in ten.

Testing it · 47

See all 47 studies that test remimazolam besilate →

As the comparator · 2 — what is tested is compared with remimazolam besilate

Codes

What other systems call remimazolam besilate · ClinicalTrials.gg INT014435

  • UNII (FDA) 280XQ6482HREMIMAZOLAM BESYLATEConfirmed FDA, Wikidata
  • RxNorm 2383942One source FDA
  • Wikidata Q27254247remimazolam besilateConfirmed FDA, Wikidata
  • DrugBank DBSALT002953One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.